Tarasiuk and Reuveni also reported similar results in a
much smaller study population that compared healthcare
use in children with SDB. They compared children with
SDB who were treated with T&A with children with SDB
who did not undergo surgery. T&A significantly reduced
health care use by 30% in children with SDB, a percentage
that is similar to what is reported in this study. Not
surprisingly, and in keeping with the results of this study,
Thus,
identifying children with SDB/adenotonsillar hypertrophy
for T&A who also have adenotonsillar infections and a high
use of outpatient services is likely to result in the most
significant reduction in costs. However, at 2 years, the costs
of the procedure are greater than the savings because of the
reduction in outpatient and antibiotic costs.
increased morbidity among children with SDB was mainly
related to upper respiratory tract infections